Drug intelligence / Profile preview

Androstenol

Development stage: Unknown
Modality: Small Molecules
Administration: Inhalation, Intranasal, Topical

Overview

Androstenol (5alpha-androst-16-en-3alpha-ol) is a naturally occurring steroid belonging to the class of androgens and derivatives. It is a C19 steroid with a hydroxyl group at the 3-position and an unsaturation between carbons 16 and 17. Androstenol acts as a pheromone in humans and other mammals, contributing to social and sexual signaling. It is not primarily used as a pharmaceutical drug but has been studied for its role in olfactory communication. Its mechanism of action involves binding to olfactory receptors rather than classical hormone receptors.

Other names: 5alpha-androst-16-en-3alpha-olandrostenol

Targets

OR (Olfactory receptors)

Beyond the preview

Go deeper on Androstenol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Androstenol.

Explore the full profile